Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Short Interest Up 34.8% in February

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) saw a significant increase in short interest in February. As of February 13th, there was short interest totaling 18,241 shares, an increase of 34.8% from the January 29th total of 13,527 shares. Based on an average daily volume of 24,613 shares, the days-to-cover ratio is presently 0.7 days. Approximately 2.0% of the company’s shares are short sold. Approximately 2.0% of the company’s shares are short sold. Based on an average daily volume of 24,613 shares, the days-to-cover ratio is presently 0.7 days.

Virtus LifeSci Biotech Clinical Trials ETF Stock Performance

Virtus LifeSci Biotech Clinical Trials ETF stock traded down $0.11 during trading hours on Monday, reaching $42.36. The stock had a trading volume of 17,112 shares, compared to its average volume of 24,786. The business’s 50 day moving average price is $40.57 and its 200-day moving average price is $33.67. Virtus LifeSci Biotech Clinical Trials ETF has a 52 week low of $13.42 and a 52 week high of $44.10.

About Virtus LifeSci Biotech Clinical Trials ETF

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.